MariMed Inc. (MRMD) Reports Break-Even Earnings for Q2

Financial Performance - MariMed Inc. reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.01, representing an earnings surprise of +100.00% [1] - The company posted revenues of $39.61 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2.91%, compared to year-ago revenues of $40.44 million [2] - Over the last four quarters, MariMed has surpassed consensus EPS estimates two times but has not beaten consensus revenue estimates [2] Stock Performance - MariMed Inc. shares have lost about 9.3% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The current status of estimate revisions translates into a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is -$0.01 on revenues of $42.9 million, and -$0.04 on revenues of $165.38 million for the current fiscal year [7] - The outlook for the industry can significantly impact stock performance, with the Medical - Products industry currently in the bottom 41% of Zacks industries [8]